BioSignatures Tech was recognized as one of the three winners of the Longevity Ideathon under the Entrepreneur-in-Residence (EiR) Incubation program (2025 cohort). This program is a joint initiative by the Longevity India, the Foundation for Science, Innovation, and Development (FSID) at Indian Institute of Science, and the Rainmatter by Zerodha, to foster deep tech and deep science solutions in the field of longevity and healthy Aging.
This recognition has helped us kickstart a meaningful journey toward developing science-driven solutions in the field of longevity- particularly focused on early detection of neuronal aging.
BioSignatures Tech originated with the need for better healthcare and work towards Medicine 2.0. The venture is a unique confluence of deep science with deep technology to solve clinical needs. We are driven by a large vision to unravel the language of biology to translate it into transformative early diagnosis. Our goal is to discover and validate multi-omic biomarkers- ranging from methylation signatures to genetic predictors to dysfunctional transcripts to exosomal profiles to immune proteins- that illuminate the invisible processes behind complex diseases.
At BioSignatures Tech,
We envision detecting molecular whispers
of disease before symptoms speak.
Brain to Blood
Brain pathologies leave detectable molecular traces in the bloodstream. Capturing these “brain-to-blood” signatures through minimally invasive liquid biopsy offers a powerful opportunity to develop diagnostics for early detection and disease monitoring of neurological disorders.
Our Mission
“We aim to develop accessible, ML-powered diagnostic tools that translate complex omics data into actionable insights for clinicians and patients.”
At Biosignatures Tech, we envision a future where early, accurate, and accessible diagnostics reshape the trajectory of human health, especially for neurodegenerative and age-related conditions that often go undetected until it's too late. Our mission is to harness the power of multi-omics data—including methylation, transcriptomics, and other omics layers—to discover interpretable biosignatures. We aim to integrate cutting-edge genomics with machine learning to build diagnostic tools that are not only scientifically rigorous but also ethically grounded and population specific.
“To redefine early diagnostics through interpretable multi-omic biosignatures enabling personalized, and equitable healthcare—especially for aging-related conditions”
We foresee a future where multi-omic biosignatures— inclusive, and clinically actionable—enable timely detection of aging-related and neurodegenerative conditions across diverse populations. At BioSignatures Tech, our vision is rooted in scientific rigor and human-centered design, with the goal of extending healthspan, reducing diagnostic delay, and making precision medicine a reality for all.
Our Vision
ML powered screening
Omics based diagnostics
Emphasis on Neurological health
founders@biosignaturestech.com
+91-9986972296, +1(604)653-4314
